@rachelnagarajan

rachel nagarajan

@rachelnagarajanJoined December 2023

In the realm of storytelling, I emerges as a captivating wordsmith.

About

Nothing here yet.

Available for

Nothing here yet.

rachel nagarajan's blogs

rachel nagarajan's blogveedaindia.hashnode.dev12 posts

Techniques and Tools for Accurate Small Molecule Analysis

Small molecule analysis is an indispensable process in various scientific fields, particularly in pharmaceuticals, biotechnology, and environmental sciences. It involves identifying, characterizing, and quantifying compounds with low molecular weight...

Dec 30, 2024 · 3 min readveedaindia.hashnode.dev

Ensuring Safety in First in Human Clinical Trials

First in Human (FIH) studies are a critical step in drug development, where a new drug or therapeutic is administered to humans for the first time. These studies play a pivotal role in determining the safety, tolerability, pharmacokinetics (PK), and ...

Nov 26, 2024 · 4 min readveedaindia.hashnode.dev

The Future of Small Molecule Analysis in Drug Discovery

Small molecule analysis is a cornerstone of drug discovery, playing a vital role in identifying and characterizing potential therapeutic agents. As the pharmaceutical landscape continues to evolve, so too does the technology and methodology for analy...

Oct 15, 2024 · 4 min readveedaindia.hashnode.dev

Phase III Clinical Trials: Evaluating Efficacy and Safety for Regulatory Approval

Phase III clinical trials represent a pivotal stage in the drug development process, where the efficacy and safety of an investigational drug are rigorously tested in large patient populations. These trials are critical for determining whether a new ...

Sep 18, 2024 · 6 min readveedaindia.hashnode.dev

Conducting Bioequivalence Studies in India: Regulatory Insights and Best Practices

Bioequivalence studies are essential for demonstrating that a generic drug has the same bioavailability as its branded counterpart. Conducting these studies in India involves navigating regulatory requirements and adopting best practices to ensure co...

Jul 22, 2024 · 4 min readveedaindia.hashnode.dev

rachel nagarajan

About

Available for

rachel nagarajan's blogs

Techniques and Tools for Accurate Small Molecule Analysis

Ensuring Safety in First in Human Clinical Trials

The Future of Small Molecule Analysis in Drug Discovery

Phase III Clinical Trials: Evaluating Efficacy and Safety for Regulatory Approval

Conducting Bioequivalence Studies in India: Regulatory Insights and Best Practices

Search Hashnode

rachel nagarajan

About

Available for

rachel nagarajan's blogs

Techniques and Tools for Accurate Small Molecule Analysis

Ensuring Safety in First in Human Clinical Trials

The Future of Small Molecule Analysis in Drug Discovery

Phase III Clinical Trials: Evaluating Efficacy and Safety for Regulatory Approval

Conducting Bioequivalence Studies in India: Regulatory Insights and Best Practices